1. Home
  2. IMAX vs DAWN Comparison

IMAX vs DAWN Comparison

Compare IMAX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$40.68

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.21

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
DAWN
Founded
1967
2018
Country
Canada
United States
Employees
N/A
181
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
IMAX
DAWN
Price
$40.68
$21.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
9
Target Price
$44.44
$27.11
AVG Volume (30 Days)
987.0K
2.3M
Earning Date
06-01-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
N/A
EPS
0.63
N/A
Revenue
$410,212,000.00
$158,182,000.00
Revenue This Year
$9.80
$53.52
Revenue Next Year
$7.11
$27.10
P/E Ratio
$64.39
N/A
Revenue Growth
16.47
20.60
52 Week Low
$20.48
$5.64
52 Week High
$43.16
$13.20

Technical Indicators

Market Signals
Indicator
IMAX
DAWN
Relative Strength Index (RSI) 61.80 82.69
Support Level $35.94 $6.40
Resistance Level $43.16 N/A
Average True Range (ATR) 1.68 0.77
MACD 0.27 0.65
Stochastic Oscillator 66.11 99.73

Price Performance

Historical Comparison
IMAX
DAWN

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: